Vyas Tungaturti is a seasoned M&A operator and advisor specializing in large-scale mergers, acquisitions, and private equity due diligence. His experience spans integration and divestiture office leadership, complex cross-border transactions, and the application of AI and machine learning to deal execution. Founder of CorpDev.Org and builder of Kai, an AI due-diligence platform for deal teams, Vyas writes on deal intelligence, value creation, and how AI is reshaping M&A and PE workflows.
TL;DR
A mining investment vehicle linked to former Secretary of State Mike Pompeo is pursuing an aggressive copper consolidation strategy, aiming to acquire up to 10 assets over the next 3-5 years,...
TL;DR
Netflix has proposed an $83 billion acquisition of Warner Bros. Discovery, a transformative cross-border M&A transaction aimed at consolidating content libraries and bolstering original...
TL;DR
Mubadala Capital has exited its minority stake in Arcadia Consumer Healthcare, with majority owner Bansk Group assuming full control through a continuation vehicle backed by Coller Capital and...
TL;DR
University of Michigan regents have publicly opposed a proposed $2.4 billion private equity investment in Big Ten Conference media rights, citing concerns over long-term control and...
TL;DR
JPMorgan Chase and Allen & Co. are set to collect approximately $180 million in advisory fees from the sale of Warner Bros. Discovery (WBD), which has an enterprise value of $77.9 billion....
TL;DR
Leidos Holdings Inc. will acquire ENTRUST Solutions Group from Kohlberg & Co. for $2.4 billion in an all-cash deal, funded by debt and cash on hand. The transaction expands Leidos' energy...
TL;DR
Merck & Co. terminated acquisition talks with Revolution Medicines for a potential $28-32 billion deal, causing Revolution's stock to plunge 20%. The collapse stemmed from a valuation...
TL;DR
Milan-based Bending Spoons acquired Vimeo for approximately $1.38 billion in November 2025 and laid off nearly the entire workforce on January 20, 2026. The move followed a 10% staff reduction...
TL;DR
The median expert forecast for Artificial General Intelligence (AGI) has dramatically shortened, with a 2026 consensus poll now placing the timeline at 2029, a sharp pull-in from 2042 in 2022....
TL;DR
BioCryst Pharmaceuticals Inc. completed its all-cash acquisition of Astria Therapeutics Inc. for $700 million on January 23, 2026. This transaction significantly enhances BioCryst's leadership...
